Distinct Immunomodulatory and Migratory Mechanisms Underpin the Therapeutic Potential of Human Mesenchymal Stem Cells in Autoimmune Demyelination
β Scribed by Payne, Natalie L. (author);Sun, Guizhi (author);Mcdonald, Courtney (author);Layton, Daniel (author);Moussa, Leon (author);Emerson-Webber, Ashley (author);Veron, Nadege (author);Siatskas, Christopher (author);Herszfeld, Daniella (author);Price, John (author);Bernard, Claude C.A. (author)
- Book ID
- 119991266
- Publisher
- Cognizant Communication Corporation
- Year
- 2013
- Tongue
- English
- Weight
- 803 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0963-6897
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Summary Autoimmune inner ear disease is characterized by progressive, bilateral although asymmetric, sensorineural hearing loss. Patients with autoimmune inner ear disease had higher frequencies of interferonβΞ³βproducing T cells than did control subjects tested. Human adiposeβderived mesenchymal
We investigated the effect of human umbilical mesenchymal stem cells (HUMSCs) from Wharton's jelly on carbon tetrachloride (CCl 4 )-induced liver fibrosis in rats. Rats were treated with CCl 4 for 4 weeks, and this was followed by a direct injection of HUMSCs into their livers. After 4 more weeks of